Stocks Health care AUTL
NASDAQ · Health careAutolus Therapeutics plc (AUTL)
Autolus Therapeutics plc brought in $117.4M of revenue over the twelve months to June 30, 2026, up 292.2% from a year earlier. It posted a net loss of $280.2M. In fiscal 2025 capital spending exceeded operating cash flow by $302.6M. At June 30, 2026 it held $171.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
What Autolus Therapeutics plc does
Autolus Therapeutics plc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker AUTL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $75.4M | -$287.5M | -$1.08 | -$302.6M |
| 2024 | $10.1M | -$220.7M | -$0.86 | -$228.3M |
| 2023 | $1.7M | -$208.4M | -$1.20 | -$156.6M |
| 2022 | n/a | -$148.8M | -$1.57 | -$123.1M |
| 2021 | n/a | -$142.1M | -$1.97 | -$126.7M |
| 2020 | n/a | -$142.1M | -$2.76 | -$132.4M |
Latest SEC filings
What Autolus Therapeutics plc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026
- September 15, 2026Form DEL AM filing DEL AM
- September 14, 2026
- August 28, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026
- August 11, 2026
- August 3, 2026
- August 3, 2026
- June 29, 2026
Questions about AUTL
What does Autolus Therapeutics plc do?
Autolus Therapeutics plc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker AUTL.
Is Autolus Therapeutics plc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $280.2M on revenue of $117.4M.
How much revenue does Autolus Therapeutics plc make?
Over the twelve months to June 30, 2026 Autolus Therapeutics plc reported revenue of $117.4M. That is 292.2% more than a year earlier.
When did Autolus Therapeutics plc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the securities offering prospectus from September 22, 2026.
Similar companies
Follow AUTL
Get an email when Autolus Therapeutics plc files with the SEC: results, executive changes, material agreements and annual reports.
Follow AUTL: get an email when it filesWhere the numbers come from
Financial figures are the values Autolus Therapeutics plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.